Press Releases

The DZHK is inviting applications for a second central biobank for its Heart Bank. Biobanks at research institutions in Germany may apply until 31…

Digital illustration of a heart shape composed of numerous glowing square pixels in shades of red, pink, orange, turquoise and blue against a dark background.

An algorithm developed at the University Medical Centre Hamburg-Eppendorf (UKE) calculates an individual's probability of having had a heart attack.…

Anatomical illustration of the mediastinum showing the heart with adjacent major vessels (aorta and pulmonary arteries in red, superior vena cava in blue) alongside the trachea and main bronchi in an upright orientation. The lymphatic system is depicted as a network of teal-colored vessels with oval lymph nodes running along the trachea, bronchi, and heart surface. Faint outlines of both lung fields are shown in the background.

As we age, the network of lymphatic vessels in the heart diminishes. Researchers at the DZHK's Frankfurt site have found that this decline in…

Researchers at the Munich site of the German Centre for Cardiovascular Research (DZHK) have discovered a previously unknown control mechanism by which…

Photo of Dr Jan Kölemen standing in front of his scientific poster at the ESC Congress, titled "From evidence to practice: Mavacamten in obstructive Hypertrophic Cardiomyopathy – data from the multicenter TORCH-Plus-DZHK21". He is wearing glasses, a dark suit, light blue tie, and an ESC Congress lanyard with name badge, smiling at the camera.

How does a new medicine perform once it is used in everyday clinical practice after approval? This is the question being investigated jointly by the…

Group photo of the TRIC-I-HF study team standing in front of a DZHK (German Centre for Cardiovascular Research) sign at the Munich site, in white lab coats: three men at the back and one woman wearing a green lanyard in the front centre.

Study by the German Centre for Cardiovascular Research (DZHK), led by LMU University Hospital Munich, demonstrates for the first time benefits in hard…

Portrait photo of a man with curly, dark blond hair and a beard, wearing a blue-and-white checked shirt and a grey blazer, smiling at the camera against a neutral light grey background.

Heidelberg-based biotech company REVIER Therapeutics has officially launched. The company, which emerged from research conducted at the German Centre…

Illustration of a blood vessel with flowing red blood cells and deposits along the vessel wall, overlaid with a large, semi-transparent cannabis leaf.

The so-called cannabinoid receptor was originally discovered because active compounds from the cannabis plant bind to it. In fact, however, it belongs…

Cross-section of a blood vessel with atherosclerotic plaque severely narrowing the vessel lumen.

A spatial analysis of proteins in human blood vessels shows why some deposits tear more easily. A team from the DZHK site in Munich reports on this in…

A close-up of a person wearing a light grey shirt, holding a small white medicine bottle and pouring tablets into their open hand.

An analysis of the DECLARE-TIMI 58 trial shows that carriers of cardiomyopathy-related genes benefit disproportionately from dapagliflozin. The…

Press releases

DZHK Calls for Applications for Second Central Biobank for the Heart Bank

ACS Pathfinder Approved as a Medical Device: Algorithm Supports Heart Attack Diagnosis

Fewer cardiac lymphatic vessels promote inflammation and cardiac ageing

How the spleen regulates the proportion of activated platelets in the blood

DZHK registry shows how new therapies perform in routine clinical care

Minimally Invasive Tricuspid Valve Repair Reduces Mortality and Hospitalisations

From Cardiovascular Research to a Biotech Company: REVIER Therapeutics Launches with €6 Million

Cannabinoid receptor identified as new target against atherosclerosis

Why some plaques become dangerous

SGLT2 inhibitor effectively protects against heart failure in individuals with genetic risk